COPD Management in the ICU
Transcript of COPD Management in the ICU
![Page 1: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/1.jpg)
COPD Management in the ICU December 2, 2011
![Page 2: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/2.jpg)
Disclosures
• I am on the Speaker’s Bureau for the following companies: – Grifols, CSL Behring, Genentech
• There is no conflict of interest as it pertains to
this presentation
![Page 3: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/3.jpg)
Objectives
• Discuss the risks and management of COPD exacerbation
• Review methods to monitor waveforms on the invasive and non-invasive mech ventilator
• Discuss Pneumothorax management • Cryptogenic hemoptysis in COPD
![Page 4: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/4.jpg)
Case Presentation • 57 y/o Caucasian F with COPD/Emphysema phenotype Spirometry: FVC 2.67L, 53% predicted FEV1 0.87L, 24% predicted FEV1/FVC 33 FEF25-75% 0.23L, 7% predicted F/V loops show a severe obstructive defect • Complains of a 2 day worsening of dyspnea, increased sputum
production and thicker consistency. No hemoptysis. Sputum color is green
![Page 5: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/5.jpg)
Case Presentation • Height: 179cm. Weight: 95kg (BMI 29.6kg/m2), Blood pressure
140/93, HR 105, RR 29, Temp 36.8C, SpO2 96% on 2L/min
• LUNGS: Chest wall is symmetrical and equal with respirations. Diminished breath sounds bilaterally bases, noted to have wheezing in the anterior segments, 4 word conversational dyspnea
• CARDIAC: sinus tachy, positive S/S2 without murmur, rub, gallop. No RV heave or thrills, pulses are 3+/regular
![Page 6: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/6.jpg)
Case Presentation
• Current medications for COPD management – Prednisone 20 mg po q day – Advair 250/50 micrograms 1
puff BID (LABA/ICS) – ProAir HFA 90 mcg INH p.r.n. – Nebulizer machine with
albuterol 2.5 mg q.i.d. (SABA)
• He has had 3 exacerbations in the last 12 months
![Page 7: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/7.jpg)
Question
• Individuals who have acute exacerbations of COPD, as compared with individuals with COPD who do not have exacerbations, will have an increased risk of:
a. Rapid decline in lung function b. Reduced quality of life c. Increased risk of death d. All of the above
![Page 8: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/8.jpg)
Definition of COPD
• Chronic obstructive pulmonary disease (COPD) is a disease state characterized by persistent blockage of airflow from the lungs
• The airflow limitation is
usually progressive Underwhelming definition?
![Page 9: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/9.jpg)
Classifying COPD
• Should the classification be based on – Imaging? – FEV1? – Symptoms?
• What are the pulmonary complications related to
COPD that we face in the ICU? – Review gap in knowledge – Practical approach
![Page 10: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/10.jpg)
Classifying COPD
![Page 11: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/11.jpg)
CXR Differences
Emphysema CXR Normal CXR
![Page 12: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/12.jpg)
COPD/Emphysema
Normal CT Chest Upper lobe involvement
![Page 13: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/13.jpg)
COPD/Emphysema
Normal CT Chest Lower lobe involvement
![Page 14: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/14.jpg)
Modified version of Fletcher and Peto’s graph showing the decline in FEV1
![Page 15: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/15.jpg)
Trajectory of a Patient with COPD Which is the most important part?
Symptoms, FEV1, 6 min walk, BODE index
Exacerbations
Exacerbations
Exacerbations Deterioration
End of Life
Donaldson GC, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-852
Time
![Page 16: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/16.jpg)
COPD Exacerbation
• Expiratory flow limitation, as a consequence of airway inflammation, is the pathophysiological hallmark of COPD
O’Donnell DE, Parker CM. COPD Exacerbation. Pathophysiology. Thorax 2006; 61: 354-361
![Page 17: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/17.jpg)
Classification of COPD severity and exacerbations
Severity FEV1 % pred
Mild Stage I ³80
Moderate Stage II 50–80
Severe Stage III 30–50
Very severe Stage IV <30
Hurst JR, et al. Susceptibility to exacerbation in COPD. N Engl J Med 2010;363:1128-1138
![Page 18: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/18.jpg)
COPD complications requiring ICU admission - Acute Exacerbation of COPD - Respiratory Failure (NIV, IV) - Pneumothorax - Hemoptysis
![Page 19: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/19.jpg)
Acute Exacerbation of COPD (AECOPD)
![Page 20: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/20.jpg)
COPD Exacerbation Definition
An acute change in the a patients baseline dyspnea, cough and/or sputum beyond day-to-day variability sufficient to warrant a change in therapy Causes of exacerbations can be both infectious and non-infectious
![Page 21: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/21.jpg)
Worse Prognosis in Frequent Exacerbators
• ≥3 acute exacerbations requiring hospitalisation is associated with a risk of death 4.30 times greater than for those patients not requiring hospitalization
Time (months)
0 10
20
30
40
50
60
0.2
0.4
0.6
0.8
1.0
Prob
abili
ty o
f sur
vivi
ng
p<0.0001
A
B
C p=0.069
p<0.0002
• Group A • Patients with no acute
exacerbations
• Group B • Patients with 1–2 acute
exacerbations of COPD requiring hospital management
• Group C • Patients with ≥3 acute
exacerbations of COPD requiring hospital management
Soler-Cataluña et al. Thorax 2005; 60:925-931
![Page 22: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/22.jpg)
Combined Assessment of COPD Predictions for Exacerbations
(C) (D)
(B) (A) R
isk
(E
xace
rbat
ion
hist
ory)
> 2
<2
mMRC > 2 CAT > 10
mMRC 0-1 CAT < 10
Ris
k
(GO
LD C
lass
ifica
tion
of A
irflo
w L
imita
tion)
Symptoms
Patient is now in one of four categories:
A: Less symptoms, low risk B: More symptoms, low risk C: Less symptoms, high risk D: More symptoms, high risk
![Page 23: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/23.jpg)
Consequences of COPD exacerbation
O’Donnell DE, Parker CM. COPD Exacerbation. Pathophysiology. Thorax 2006; 61: 354-361
![Page 24: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/24.jpg)
COPD exacerbations
• Occlusion of the bronchiolar lumen by mucus, cells, thickened/contracted smooth muscle, bronchial wall inflammation and edema
• Leads to: – Increased WOB – Low V/Q ratio – Dynamic hyperinflation
![Page 25: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/25.jpg)
COPD exacerbations
Classification 3-6% of AECOPD patients require hospitalization - Mortality ranges from 3-10% - If the ICU is required, mortality rate approaches
30% in patients older than 65 years
MacIntyre N, Huang YC. Acute exacerbations and respiratory failure in COPD. Proc Am Thor Soc 2008;5:530-535
![Page 26: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/26.jpg)
Messer B, et al. The prognostic variables of mortality in patients with an exacerbation of COPD admitted to the ICU: an integrative review. QJM 2012; 105: 115-126
![Page 27: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/27.jpg)
Mohan A, et al. Clinical presentation and predictors of outcome in patients with severe acute exacerbation of COPD requiring admission to intensive care unit. BMC Pulmonary 2006;6:27
![Page 28: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/28.jpg)
Mohan A, et al. Clinical presentation and predictors of outcome in patients with severe acute exacerbation of COPD requiring admission to intensive care unit. BMC Pulmonary 2006;6:27
![Page 29: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/29.jpg)
COPD Exacerbation Therapeutic Options
• Supplamental oxygen, goal 88-92% • Bronchodilators
– Aerosolized albuterol – Ipratropium?
• Corticosteroids • Antibiotics • Management of Respiratory Failure
– Non-invasive mechanical ventilation – Invasive Mechanical ventilation
![Page 30: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/30.jpg)
COPD Exacerbation Antibiotics
• Indications – Increased dyspnea, sputum quantity and quality
(purulence) – Mechanical ventilation
• Organisms – Spneumoniae, H Influenza, M catarrhalis
• Risk factors for PsA – Frequent antibiotics – Severe COPD exacerbations – Prior PsA – Recent health care visit
![Page 31: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/31.jpg)
Patients treated in the ICU for AECOPD
Ai-Ping C, et al. Patients treated in the ICU for acute exacerbation of COPD. Chest 2005; 128:518-524
![Page 32: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/32.jpg)
• Median ICU days 3 d • Median hospital stay 9 d • In-hospital mortality 24.5% • Of the survivors who were
discharged – Most required readmission
for exacerbation – Median time to the next
exacerbation: 5 months – Those who required a
second ICU admission had a mortlality rate of 39% at 6 months, 42.7% at 1 year, 61.2% at 3 years
Ai-Ping C, et al. Patients treated in the ICU for acute exacerbation of COPD. Chest 2005; 128:518-524
![Page 33: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/33.jpg)
Respiratory Failure
![Page 34: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/34.jpg)
COPD Exacerbation Respiratory Failure
• Type I: Hypoxemic respiratory failure is characterized by pO2 < 60 mmHg with a normal or low pCO2
• Type II: Hypercapnic respiratory failure is characterized by pCO2 > 50 mmHg (unless having a chronic feature) – Acute form develops within minutes to hours;
therefore, pH <7.3
![Page 35: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/35.jpg)
Non-invasive Mechanical Ventilation
![Page 36: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/36.jpg)
Case Presentation
• You receive a page from the ER. • The patient was placed on BiPAP and feels
”better” • Vent settings are: FiO2 100%, IPAP 8/EPAP 4 • Is there anything else you want to know? • When do you want to check up on her
![Page 37: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/37.jpg)
COPD Exacerbation Non-invasive mechanical ventilation
• Indications – Accessory muscle use, short of respiratory
failure/agonal breathing – Patient cooperative (exclused agitation, belligerent,
coma) – Showing signs of retaining pCO2
• Assess the pCO2 with the respiratory rate, not what a normal value is (pH 7.1-7.3)
• RR> 25
– Hypoxemia; P/F ratio < 200
![Page 38: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/38.jpg)
COPD Exacerbation Contraindications to NIV
• Cardiovascular instability • Inability to protect airway
– Impaired mental status (GCS <8) – Aspiration risks, recent facial surgery or injury – Poor clearance of secretions
• Potential for upper airway obstruction – Angioedema – Extrinsic compression of the trachea (eg. tumor,
hematoma)
![Page 39: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/39.jpg)
![Page 40: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/40.jpg)
Benefits of NIV
• Symptomatic relief of dyspnea • Correction of gas exchange • Improve lung mechanics • Decrease mortality associated with resp failure • Prevent intubation and associated
complications: – Tracheal stenosis, VAP, tracheostomy need, GI
bleed, DVT, mopathy
![Page 41: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/41.jpg)
Benefits of NIV
• Unload respiratory muscle inspiratory cycle: – Hyperinflation >> resp muscle shortening – Decrease compliance of respiratory system
• Overcome intrinsic PEEP • Stent open lower airway expiratory cycle
– Overcome the dynamic airway collapse in the expiratory phase and coughing episodes
• Stent open upper airway – Associated OSA
![Page 42: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/42.jpg)
Non-invasive ventilation for acute exacerbation of COPD INCLUSION CRITERIA COPD with exacerbation of dyspnea > two days and at least two of the following:
RR>30 PaO2 < 45 mm Hg pH < 7.35 after > 10 min on RA
EXCLUSION CRITERIA RR< 12 breaths, sedative drugs within the previous 12 hours CNS disorder unrelated to hypercapnic encephalopathy or hypoxemia Cardiac arrest (within the previous five days) Cardiogenic pulmonary edema Asthma
Brochard et al. NEJM 1995, supportive ventilation RCT
![Page 43: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/43.jpg)
Non-invasive ventilation for acute exacerbation of COPD EXCLUSION CRITERIA • kyphoscoliosis as the cause of chronic respiratory failure • neuromuscular disorder as the cause of chronic
respiratory failure • Upper airway obstruction, facial deformity, tracheotomy • need for immediate intubation = a clear cause of
decompensation requiring specific treatment (e.g., peritonitis, septic shock, AMI)
• pulmonary thromboembolism • pneumothorax, hemoptysis • severe pneumonia • recent surgery or trauma
![Page 44: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/44.jpg)
Non-invasive ventilation for acute exacerbation of COPD
• Primary Outcome: Need for intubation • Secondary outcomes:
– hospital LOS – Complications – Length on mechanical ventilation – In hospital mortality
![Page 45: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/45.jpg)
Non-invasive ventilation for acute exacerbation of COPD • Standard treatment arm
– O2 via nasal canula up to 5L for target SpO2 > 90% – Antibiotics, bronchodilators, iv steroids or
aminophylline
• NIV treatment arm – Standard treatment above + : – BIPAP for at least 6 hours/day, nasal cannula for at
least 2 hours/day – IPAP=20, EPAP=0, flow cycled
![Page 46: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/46.jpg)
Non-invasive ventilation for acute exacerbation of COPD Major Criteria for intubation:
–respiratory arrest, pauses with LOC, gasping, requiring sedation, HR<50 with lethargy, SPB<70
Minor Criteria for intubation: –RR> 35 and > on admission, pH < 7.3 and < admission, PaO2<45 despite O2, worsening MS
One Major Criteria or 2 Minor Criteria after one hour of RX would be indication for intubation. In the NIPPV group if 2 minor criteria met off NIV, they can be placed back on it. But if problem persisted then intubation performed
![Page 47: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/47.jpg)
![Page 48: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/48.jpg)
Non-invasive ventilation for acute exacerbation of COPD
•85 patients total –42 standard rx (ST) group à 31 intubated (74%) –43 NIPPV rx group à 11 intubated (26%) –ARR = 48%, NNT= 2
• Major criteria for intubation met by 10/31 (ST) and 8/11 (NIPPV) • At 1 hour:
–NIPPV group: •improved encephalopathy, rr, PaO2, pH
– Standard group: •worsening enceph, PaCO2, pH
![Page 49: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/49.jpg)
Encephalopathy score 1= mild asterixis, 2= marked asterixis, mild confusion, sleepy during the day 3= major confusion with daytime sleepiness or agitation
![Page 50: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/50.jpg)
Recommended algorithm
Noninvasive ventilation in acute exacerbations of COPD M.W. Elliott, Eur Respir Rev 2005
![Page 51: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/51.jpg)
Rapid Shallow Breathing index
• RBSI = respiratory frequency/Vt
RBSI < 105 (n= 83)
RBSI > 105 (n= 18)
Requiring intubation
26 patients (31%)
10 patients (55%)
In-hospital mortality
7 patients (8.4%)
6 patients (33%)
Berg KM, et al. The rapid shallow breathing index as a predictor of failure on non-invasive ventilation
![Page 52: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/52.jpg)
Invasive Mechanical Ventilation
![Page 53: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/53.jpg)
COPD Exacerbation Invasive mechanical ventilation
• Indications – Accessory muscle use – Showing signs of retaining pCO2
• Assess the pCO2 with the respiratory rate, not what a normal value is
• Does not meet criteria for NIPPV • RR> 35
![Page 54: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/54.jpg)
Case Presentation
• You receive a page from the ER. • The patient was intubated • Vent settings are: FiO2 100%, Vt 500cc, RR 18, PEEP 5
• You are asked, “Is there anything else you need
to know?”
![Page 55: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/55.jpg)
COPD Respiratory Failure Invasive mechanical ventilation
• Mechanical ventilation principles are to balance out airway pressures with gas exchange
• Additional information you need to know are: – PIP, plateau, expiratory Vt, I:E time – waveforms – ABG
![Page 56: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/56.jpg)
COPD Respiratory Failure Invasive mechanical ventilation
• Ventilator mode – Volume ventilation in the AC or SIMV mode – Or pressure ventilation—either PRVC or PC
• Tidal volume and respiratory rate
– Good starting point: 10 ml/kg and 10 to 12 bpm – A small tidal volume (5-8 ml/kg) and 8 to 10 bpm with
increased flow rates to allow adequate expiratory time
![Page 57: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/57.jpg)
COPD Exacerbation Invasive mechanical ventilation
• Flow rate – 60 L/min
• I:E ratio – 1:2 or 1:3
• General goals and/or concerns – Air-trapping and auto-PEEP can occur when
expiratory time is too short – ↑ Expiratory time to offset auto-PEEP – May ↑ inspiratory flow up to 100 L/min to ↑ expiratory time – May ↓ VT or rate to ↑ expiratory time – Do not overventilate COPD patients with chronically
high PaCO2 levels
![Page 58: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/58.jpg)
COPD Exacerbation Invasive mechanical ventilation
• Vent settings: – Use a slow respiratory rate to reduce the risk of air-
trapping – Auto-PEEP: consider matching extrinsic PEEP if the
patient appears to have difficulty triggering the ventilator
![Page 59: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/59.jpg)
Mechanical Ventilation • Vent settings:
– Mode A/C, PC – FiO2 21%-100% – Vt (6-10cc/kg) or Pressure setting (15-20 cmH2O) – RR (10-30/min) – PEEP 0-24 cmH2O
• Patient monitors:
– Difference between inspiratory and expiratory Vt • leaks
– PIP, Plateau, I:E ratio – Waveforms
![Page 60: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/60.jpg)
Byrd RP, et al. Mechanical Ventilation. Medscape
![Page 61: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/61.jpg)
Airway Pressures Resistance vs. Compliance
• Peak Pressures – Airway resistance AND compliance – Keep below 40-45 cm H2O
• Plateau Pressures (EIP) – Lung and chest wall compliance – Keep below 30 cm H2O
• Normal difference between PIP and plateau
pressure is up to 10 cmH2O
![Page 62: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/62.jpg)
Compliance
• Lung compliance is the ability of the lung to stretch during a change in volume relative to an applied change in pressure
• Compliance is greatest at moderate lung volumes, and much lower at volumes which are very low or very high – LIP and UIP are good guidelines
• Low compliance indicates a stiff lung and extra work may be required to bring it in a normal volume
![Page 63: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/63.jpg)
Trouble Shooting the Ventilator
High Peak Pressures
Low Plateau Pressures
High Peak Pressures
High Plateau Pressures
Mucus Plug ARDS
Bronchospasm Pulmonary Edema
ET tube blockage Pneumothorax
Biting ET tube migration to a single bronchus
Effusion
*** Compliance can also be viewed on the waveforms
![Page 64: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/64.jpg)
![Page 65: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/65.jpg)
O’Donnell DE, Parker CM. COPD Exacerbation. Pathophysiology. Thorax 2006; 61: 354-361
![Page 66: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/66.jpg)
![Page 67: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/67.jpg)
Resistance vs. Compliance
Byrd RP, et al. Mechanical Ventilation. Medscape
![Page 68: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/68.jpg)
Considerations in providing invasive PPV for COPD patients
• Regional over-distention injury applies to COPD
patients just as it does to ARDS patients
• Hence, strategies should be similar to protecting healthy lung units in other forms of respiratory failure
![Page 69: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/69.jpg)
Ventilator Associate Lung Injury (VALI)
Mechanical over-distension or shearing
![Page 70: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/70.jpg)
Ventilator Associate Lung Injury (VALI)
• The propensity to injury is related partly to the inhomogeneity in distensibility of injured lungs
• The open and thus relatively healthy lung parts will be prone to overinflation, while the injured lung areas will not be inflated
• When this lung is inflated, even with small Vts, air will go preferentially to these open still compliant parts
“tidal overdistension”
![Page 71: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/71.jpg)
These forces include repetitive (cyclic) strain (stretch) from overdistension and interdependence and shear stress to the epithelial cells as lung units collapse and reopen, atelectrauma
Ventilator Associate Lung Injury (VALI)
![Page 72: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/72.jpg)
Methods of recruitment
• Vt • RR • PEEP • I:E
![Page 73: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/73.jpg)
Problem of this heterogeneity
• Finding the right balance of Vt, RR and PEEP to keep the lungs open without generating high pressure is the goal
• This may be a challenge when these are at a constant setting without a dynamic response to the lungs signals being provided – e.g. waveforms, compliance trends
![Page 74: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/74.jpg)
Upper inflection point
Lower inflection point
![Page 75: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/75.jpg)
Byrd RP, et al. Mechanical Ventilation. Medscape
![Page 76: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/76.jpg)
Byrd RP, et al. Mechanical Ventilation. Medscape
![Page 77: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/77.jpg)
Pulmonary Injury
• 2 injury zones during mechanical ventilation use – Low lung volumes
tears adhesive surfaces
– High volumes cause barotrauma
![Page 78: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/78.jpg)
Upper inflection point
• It is predicted that a transpulmonary pressure of 30 cm H2O could result in shear forces of 140 cm H2O
• Shear forces, the frequency and end-inspiratory overstretching may all place a role in epithelial disruption and loss of barrier function of the alveolar epithelium
![Page 79: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/79.jpg)
Physiology of PEEP Opens up collapsed alveoli and prevents alveolar collapse during exhalation PEEP Decreases alveolar distending pressure Increases FRC by alveolar recruitment Improves ventilation Increases V/Q, improves oxygenation, decreases work of breathing
![Page 80: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/80.jpg)
Over distention
• An increase in airway pressure at the end of inspiration without a significant increase in delivery of tidal volume – ‘beaking’ at the end of inspiration
![Page 81: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/81.jpg)
Upper inflection point
Lower inflection point
Optimal PEEP • PEEP should be high enough to shift the end-expiratory pressure above the lower inflection point by 2-3 cm H2O (usually 12-15 cm H2O) • Allows maximal alveolar recruitment • Decrease injury by repeated opening and closing of small airways
![Page 82: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/82.jpg)
![Page 83: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/83.jpg)
![Page 84: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/84.jpg)
Intrinsic PEEP/Air trapping
• Determined by – Minute ventilation
(frequency x Vt) – I:E ratio
• To fix it,
– Decrease minute vent (either frequency or Vt)
– Prolong I:E
![Page 85: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/85.jpg)
Complications associated with PEEP
• Barotrauma • Regional hypoperfusion • Paradoxical hypoxemia • Hypercapnea and respiratory acidosis • Diminished cardiac output • Augmentation of ICP • Pulmonary edema
![Page 86: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/86.jpg)
High PEEP • In rats ventilated with PEEP
10 and a peak Pressure 45, no injury was present
• Rats with PEEP 0 and a peak Pressure 45, severe pulmonary edema was present within 20 minutes
• Subsequent study showed a preservation of the structure of the alveolar epithelium by using PEEP 10, which was accompanied by the lack of alveolar flooding
![Page 87: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/87.jpg)
Pneumothorax associated with COPD
![Page 88: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/88.jpg)
Case Presentation
• Your patient had developed a Pneumothorax during the night. A heimlich valve was placed.
• You are told that there was an air leak.
• You ask yourself, the following 2 questions: 1. “Are all air leaks the same?” 2. “Does this impact mortality?”
![Page 89: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/89.jpg)
Pneumothorax in COPD
• Incidence: 4-15% in mechanically vented patients
– Tension PTX more – Mortality rate: 46-77%
• High airway pressures are required to overcome severe bronchial obstruction. However, because of a variability of obstruction in the different airways, there is a mal-distribution of mechanical tidal volume, which promotes gas trapping and non-uniform alveolar distention
Hsu CW, Sun SF. Iatrogenic pneumothorax related to mechanical ventilation. World J Crit Care Med 2014; 3: 8-14
![Page 90: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/90.jpg)
Pneumothorax in COPD
• Defined as a spontaneous secondary PTX – More severe than primary spontaneous PTX – Rapidly progressive – Mortality rate 16%
• Cause of death: sudden death before chest tube insertion, respiratory failure within the first 24 hours, massive gastrointestinal bleeding
• Most COPD patients developing a spontaneous secondary pneumothorax: – Age older than 50 years – FEV1 < 1.0L
![Page 91: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/91.jpg)
Algorithm to PTX related to mech vent
To achieve this goal, ACCP Recommendation for secondary PTX; use a 16 French catheter or larger
![Page 92: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/92.jpg)
Treatment Goals with the Chest Tube 1. Evacuate air from the
pleural space 2. Achieve pleural-pleural
apposition 3. Decrease likelihood of
recurrence • The median time to
resolve air leaks in COPD patient is longer than primary spont PTX – In 20% of COPD patients;
median day is 15 days – 44% recurrence rate
Shen KR, Cerfolio RJ. Decision making in the management of secondary spontaneous pneumothorax In patients with severe emphysema. Thorac Surg Clin 2009; 19:233-238
![Page 93: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/93.jpg)
![Page 94: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/94.jpg)
Pneumothorax in COPD
Cerfolio RJ. Advances in thoracostomy tube management. Surg Clin N Am 2002; 82:833-848
![Page 95: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/95.jpg)
Bullae vs PTX
?
?
![Page 96: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/96.jpg)
Cryptogenic hemoptysis in COPD
![Page 97: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/97.jpg)
Cryptogenic hemoptysis in COPD
• Mild = blood tinged sputum or < 30 cc/24 hours • Moderate = 30-100 cc/24 hours • Severe (massive) = > 100 cc/24 hours
![Page 98: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/98.jpg)
Cryptogenic hemoptysis in COPD
• 39 patients ( 36 men, 3 women) – Average time of COPD dx to hemoptysis: 4.7 + 5.4 yr
• Mean age 51.3 years (24-80) • All patients were active smokers
– Duration 17.2 + 4 years – Mean total 31.7 + 15 packs
• 15 pts (38%) had cardiovascular conditions • 21 pts (54%) had predisposition for bleding
– 5 with thrombocytopenia, 5 with prolonged PTT – 11 taking medications known to cause bleeding
Delage A, et al. cryptogenic hemoptysis in COPD: Characteristics and Outcome. Respiration 2010: 80:387-392
![Page 99: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/99.jpg)
Cryptogenic hemoptysis in COPD
Delage A, et al. cryptogenic hemoptysis in COPD: Characteristics and Outcome. Respiration 2010: 80:387-392
![Page 100: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/100.jpg)
Cryptogenic hemoptysis in COPD
• No difference between CT and bronch to determine the site of bleed
• Arterial embolization succeeded in controlling bleeding in all patients who underwent the procedure
• 34 pts followed for 5 yrs; only 2 had recurrent hemoptysis. None died
Delage A, et al. cryptogenic hemoptysis in COPD: Characteristics and Outcome. Respiration 2010: 80:387-392
![Page 101: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/101.jpg)
Important fact about the lungs • The lungs are heterogeous in nature • Non-physiological ventilation in healthy lungs
induce lung injury
![Page 102: COPD Management in the ICU](https://reader038.fdocuments.in/reader038/viewer/2022102612/586177da1a28ab0e308b81de/html5/thumbnails/102.jpg)
Summary
• Pulmonary complications related to COPD can portend poor outcomes
• The need to identify “responders” to a particular therapeutic intervention is crucial – “Devil is in the detail”